These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
260 related articles for article (PubMed ID: 25028549)
21. Preparation and characterization of monensin loaded PLGA nanoparticles: in vitro anti-malarial activity against Plasmodium falciparum. Surolia R; Pachauri M; Ghosh PC J Biomed Nanotechnol; 2012 Feb; 8(1):172-81. PubMed ID: 22515105 [TBL] [Abstract][Full Text] [Related]
22. Preparation, characterization and in vitro cytotoxicity of indomethacin-loaded PLLA/PLGA microparticles using supercritical CO2 technique. Kang Y; Wu J; Yin G; Huang Z; Yao Y; Liao X; Chen A; Pu X; Liao L Eur J Pharm Biopharm; 2008 Sep; 70(1):85-97. PubMed ID: 18495445 [TBL] [Abstract][Full Text] [Related]
23. Co-delivery of curcumin and Bcl-2 siRNA to enhance therapeutic effect against breast cancer cells using PEI-functionalized PLGA nanoparticles. Mohammad Gholinia Sarpoli L; Zare-Karizi S; Heidari E; Hasanzadeh A; Bayandori M; Azedi F; Hamblin MR; Karimi M Pharm Dev Technol; 2022 Sep; 27(7):785-793. PubMed ID: 36043390 [TBL] [Abstract][Full Text] [Related]
25. Controlled release of drug and better bioavailability using poly(lactic acid-co-glycolic acid) nanoparticles. Pandey SK; Patel DK; Maurya AK; Thakur R; Mishra DP; Vinayak M; Haldar C; Maiti P Int J Biol Macromol; 2016 Aug; 89():99-110. PubMed ID: 27112980 [TBL] [Abstract][Full Text] [Related]
26. Preparation and characterization of teniposide PLGA nanoparticles and their uptake in human glioblastoma U87MG cells. Mo L; Hou L; Guo D; Xiao X; Mao P; Yang X Int J Pharm; 2012 Oct; 436(1-2):815-24. PubMed ID: 22846410 [TBL] [Abstract][Full Text] [Related]
27. Formulation of Anti-miR-21 and 4-Hydroxytamoxifen Co-loaded Biodegradable Polymer Nanoparticles and Their Antiproliferative Effect on Breast Cancer Cells. Devulapally R; Sekar TV; Paulmurugan R Mol Pharm; 2015 Jun; 12(6):2080-92. PubMed ID: 25880495 [TBL] [Abstract][Full Text] [Related]
28. PLGA Microparticles Entrapping Chitosan-Based Nanoparticles for the Ocular Delivery of Ranibizumab. Elsaid N; Jackson TL; Elsaid Z; Alqathama A; Somavarapu S Mol Pharm; 2016 Sep; 13(9):2923-40. PubMed ID: 27286558 [TBL] [Abstract][Full Text] [Related]
29. Ursolic Acid Loaded PLGA Nanoparticles: in vitro and in vivo Evaluation to Explore Tumor Targeting Ability on B16F10 Melanoma Cell Lines. Baishya R; Nayak DK; Kumar D; Sinha S; Gupta A; Ganguly S; Debnath MC Pharm Res; 2016 Nov; 33(11):2691-703. PubMed ID: 27431865 [TBL] [Abstract][Full Text] [Related]
30. Preparation and in vitro evaluation of meloxicam-loaded PLGA nanoparticles on HT-29 human colon adenocarcinoma cells. Şengel-Türk CT; Hasçiçek C; Dogan AL; Esendagli G; Guc D; Gönül N Drug Dev Ind Pharm; 2012 Sep; 38(9):1107-16. PubMed ID: 22348284 [TBL] [Abstract][Full Text] [Related]
31. Encapsulation of alpha-1 antitrypsin in PLGA nanoparticles: in vitro characterization as an effective aerosol formulation in pulmonary diseases. Pirooznia N; Hasannia S; Lotfi AS; Ghanei M J Nanobiotechnology; 2012 May; 10():20. PubMed ID: 22607686 [TBL] [Abstract][Full Text] [Related]
32. Preferential hepatic uptake of paclitaxel-loaded poly-(d-l-lactide-co-glycolide) nanoparticles - A possibility for hepatic drug targeting: Pharmacokinetics and biodistribution. Mandal D; Shaw TK; Dey G; Pal MM; Mukherjee B; Bandyopadhyay AK; Mandal M Int J Biol Macromol; 2018 Jun; 112():818-830. PubMed ID: 29421493 [TBL] [Abstract][Full Text] [Related]
33. The comparative study of influence of lactic and glycolic acids copolymers type on properties of daunorubicin loaded nanoparticles and drug release. Nikolskaya E; Sokol M; Faustova M; Zhunina O; Mollaev M; Yabbarov N; Tereshchenko O; Popov R; Severin E Acta Bioeng Biomech; 2018; 20(1):65-77. PubMed ID: 29658530 [TBL] [Abstract][Full Text] [Related]
34. Surface modification of PLGA nanoparticles with biotinylated chitosan for the sustained in vitro release and the enhanced cytotoxicity of epirubicin. Chen H; Xie LQ; Qin J; Jia Y; Cai X; Nan W; Yang W; Lv F; Zhang QQ Colloids Surf B Biointerfaces; 2016 Feb; 138():1-9. PubMed ID: 26638176 [TBL] [Abstract][Full Text] [Related]
35. Biodegradable nanoparticles containing doxorubicin-PLGA conjugate for sustained release. Yoo HS; Oh JE; Lee KH; Park TG Pharm Res; 1999 Jul; 16(7):1114-8. PubMed ID: 10450940 [TBL] [Abstract][Full Text] [Related]
37. Design and in vitro evaluation of biocompatible dexamethasone-loaded nanoparticle dispersions, obtained from nano-emulsions, for inhalatory therapy. Fornaguera C; Llinàs M; Solans C; Calderó G Colloids Surf B Biointerfaces; 2015 Jan; 125():58-64. PubMed ID: 25437064 [TBL] [Abstract][Full Text] [Related]
38. Comparative studies on chitosan and polylactic-co-glycolic acid incorporated nanoparticles of low molecular weight heparin. Yang T; Nyiawung D; Silber A; Hao J; Lai L; Bai S AAPS PharmSciTech; 2012 Dec; 13(4):1309-18. PubMed ID: 23054983 [TBL] [Abstract][Full Text] [Related]
39. Simultaneous Targeting of Differentiated Breast Cancer Cells and Breast Cancer Stem Cells by Combination of Docetaxel- and Sulforaphane-Loaded Self-Assembled Poly(D, L-lactide-co-glycolide)/Hyaluronic Acid Block Copolymer-Based Nanoparticles. Huang J; Tao C; Yu Y; Yu F; Zhang H; Gao J; Wang D; Chen Y; Gao J; Zhang G; Zhou G; Liu J; Sun Z; Sun D; Zou H; Xu H; Lu Y; Zhong Y J Biomed Nanotechnol; 2016 Jul; 12(7):1463-77. PubMed ID: 29337484 [TBL] [Abstract][Full Text] [Related]
40. Synthesis and Characterization of PLGA-PEG Thymoquinone Nanoparticles and Its Cytotoxicity Effects in Tamoxifen-Resistant Breast Cancer Cells. Ahmad R; Kaus NHM; Hamid S Adv Exp Med Biol; 2020; 1292():65-82. PubMed ID: 30560443 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]